3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Prostatic Neoplasms
17
Urinary Bladder Neoplasms
10
Kidney Neoplasms
6
Pancreatic Neoplasms
4
Neoplasms
4
Head and Neck Neoplasms
4
Ovarian Neoplasms
3
Neoplasm Metastasis
3
Melanoma
3
Lung Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Renal Cell
3
Breast Neoplasms
3
Wilms Tumor
2
Uterine Cervical Neoplasms
2
Testicular Neoplasms
2
Stomach Neoplasms
2
Skin Neoplasms
2
Sarcoma
2
Muscle-invasive Bladder Cancer
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Liver Neoplasms
2
Laryngeal Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Cholangiocarcinoma
2
Central Nervous System Neoplasms
2
Carcinoma, Transitional Cell
2
Interventions
Filgrastim
3
belinostat
2
Gemcitabine
2
Docetaxel
2
Carboplatin
2
tazemetostat
1
resiquimod
1
poly ICLC
1
etoposide phosphate
1
durvalumab
1
Topotecan
1
Thiotepa
1
Thalidomide
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiotherapy, Conformal
1
Radiosurgery
1
Quality of Life
1
Peripheral Blood Stem Cell Transplantation
1
Pentetic Acid
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Minocycline
1
Immunotherapy
1
Imatinib Mesylate
1
Ifosfamide
1
Heparin
1
Gelclair
1
Fluorouracil
1
Fentanyl
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chondrosarcoma
×
Drug Therapy
×
Genitourinary
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled